Boston Scientific Corporation vs ABRDN Physical Gold Shares ETF — how do they compare? Boston Scientific Corporation trades at $51.15 (market cap $74.19B), while ABRDN Physical Gold Shares ETF trades at $41.95. The key difference: ABRDN Physical Gold Shares ETF is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | SGOL | |
|---|---|---|
Market Cap | $74.19B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $108.14 | $51.41 |
52-Week Low | $42.63 | $31.61 |
Enterprise Value | $86.27B | — |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →